Search - tctmd.com

Displaying 1 - 20 of 72

Sort: Relevancy | Date

Presentation TCT 2025

Evaluation of the Safety and One-Year Efficacy of the Novel Neoblazar® Transcatheter Edge-to Edge Repair System for Symptomatic Severe Tricuspid Regurgitation (Dawneo Medical Technology)

Presenter: Yan Wang

October 27, 2025

Presentation TCT 2025

TCT 36: Mid-term Outcomes of Patients With Severe Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Replacement

Presenter: Konstantinos Stathogiannis

October 27, 2025

Presentation TCT 2025

TCT 864: Comparative Outcomes of Tricuspid transcatheter edge-to-edge repair (T-TEER) Versus Medical Therapy (MT) in Severe Tricuspid Regurgitation (TR): A Systematic Review and Meta-analysis

Presenter: Himanshi Banker

October 27, 2025

Presentation TCT 2025

TCT 865: Impact of a Standardized Algorithm on Device Selection in Severe Tricuspid Regurgitation

Presenter: Omar Sami Abdelhai

October 27, 2025

Presentation TCT 2025

TCT 989: A physics-based computational simulation model to study transcatheter tricuspid valve replacements in patients with severe tricuspid regurgitation

Presenter: Luis Rene Mata Quinonez

October 26, 2025

Presentation TCT 2025

TCT 991: Hemodynamic and Echocardiographic Effects of TTVR in Patients with Severe Tricuspid Regurgitation

Presenter: Tobias Geisler

October 26, 2025

Presentation TCT 2025

TCT 984: Comparison of Invasive and Non-Invasive Assessment of Right Ventricular Function Using Pressure-Volume Loops in Patients with Severe Tricuspid Regurgitation Undergoing Percutaneous Tricuspid Valve Replacement

Presenter: Vivek Mehta

October 26, 2025

Presentation TCT 2025

Heterotopic TTVR in Patients with Severe Tricuspid Regurgitation: Initial Results of the Trillium EFS (Innoventric)

Presenter: Santiago Garcia

October 26, 2025

Presentation TCT 2025

A Novel Strategy Targeting Caval Reflux to Alleviate Right Heart Failure in Severe Tricuspid Regurgitation: Early Results of the TRICAV EFS of TRIcvalve (Products+Features)

Presenter: Rishi Puri

October 26, 2025

Presentation NY Valves 2025

Is There a Rebound Favoring Surgery for Severe TR… Or Is RHF Still an Exclusion

Presenter: Robert L. Smith

June 26, 2025

Presentation NY Valves 2025

Redo Transcatheter Interventions: Recurrent Severe Tricuspid Regurgitation in a Patient With Prior ViV TTVR

Presenter: Amr Mohsen

June 26, 2025

Presentation NY Valves 2025

Transcatheter Tricuspid Valve Replacement Beyond Age 75: 30-Day Outcomes in Severe Tricuspid Regurgitation

Presenter: Priscilla Wessly

June 26, 2025

Presentation NY Valves 2025

Case #1: A Patient With Symptomatic Severe TR: Repair or Replace?

Presenter: Jennifer von Stein

June 25, 2025

Presentation NY Valves 2025

Efficacy and Safety of Transcatheter Therapy for Patients With Severe Tricuspid Regurgitation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: John Cedric Mojica

June 25, 2025

Presentation THT Abstracts 2025

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Presenter: Aasim Afzal

February 11, 2025

Presentation THT 2025

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Presenter: Aasim Afzal

February 11, 2025

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

TCT 978: A Computational Modeling Strategy to Study Transcatheter Tricuspid Valve Replacements in Patients With Severe Tricuspid Regurgitation

Presenter: Luis Rene Mata Quinonez

October 29, 2024

Presentation TCT 2024

TCT 967: Real World Outcomes of Patients With Severe Tricuspid Regurgitation Stratified by Clinical Sequelae

Presenter: Mahesh Madhavan

October 29, 2024

Presentation TCT 2024

TCT 970: Cost and Healthcare Utilization by Age, Sex, and Race in the Years Leading Up to a Severe or Clinically Significant Status for Patients With Tricuspid Regurgitation

Presenter: Colin Barker

October 29, 2024

Advertisement

Evaluation of the Safety and One-Year Efficacy of the Novel Neoblazar® Transcatheter Edge-to Edge Repair System for Symptomatic Severe Tricuspid Regurgitation (Dawneo Medical Technology)

TCT 36: Mid-term Outcomes of Patients With Severe Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Replacement

TCT 864: Comparative Outcomes of Tricuspid transcatheter edge-to-edge repair (T-TEER) Versus Medical Therapy (MT) in Severe Tricuspid Regurgitation (TR): A Systematic Review and Meta-analysis

TCT 865: Impact of a Standardized Algorithm on Device Selection in Severe Tricuspid Regurgitation

TCT 989: A physics-based computational simulation model to study transcatheter tricuspid valve replacements in patients with severe tricuspid regurgitation

TCT 991: Hemodynamic and Echocardiographic Effects of TTVR in Patients with Severe Tricuspid Regurgitation

TCT 984: Comparison of Invasive and Non-Invasive Assessment of Right Ventricular Function Using Pressure-Volume Loops in Patients with Severe Tricuspid Regurgitation Undergoing Percutaneous Tricuspid Valve Replacement

Heterotopic TTVR in Patients with Severe Tricuspid Regurgitation: Initial Results of the Trillium EFS (Innoventric)

A Novel Strategy Targeting Caval Reflux to Alleviate Right Heart Failure in Severe Tricuspid Regurgitation: Early Results of the TRICAV EFS of TRIcvalve (Products+Features)

Is There a Rebound Favoring Surgery for Severe TR… Or Is RHF Still an Exclusion

Redo Transcatheter Interventions: Recurrent Severe Tricuspid Regurgitation in a Patient With Prior ViV TTVR

Transcatheter Tricuspid Valve Replacement Beyond Age 75: 30-Day Outcomes in Severe Tricuspid Regurgitation

Case #1: A Patient With Symptomatic Severe TR: Repair or Replace?

Efficacy and Safety of Transcatheter Therapy for Patients With Severe Tricuspid Regurgitation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

TCT 978: A Computational Modeling Strategy to Study Transcatheter Tricuspid Valve Replacements in Patients With Severe Tricuspid Regurgitation

TCT 967: Real World Outcomes of Patients With Severe Tricuspid Regurgitation Stratified by Clinical Sequelae

TCT 970: Cost and Healthcare Utilization by Age, Sex, and Race in the Years Leading Up to a Severe or Clinically Significant Status for Patients With Tricuspid Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content